跳转至内容
Merck

PHR1724

Supelco

氟哌啶醇

Pharmaceutical Secondary Standard; Certified Reference Material

别名:

氟哌啶醇, 4-[4-(4-氯苯基)-4-羟基-1-哌啶基]-1-(4-氟苯基)-1-丁酮, 4-[4-(4-氯苯基)-4-羟基哌啶基]-4'-氟丁酰苯, 4-[4-(对氯苯基)-4-羟基哌啶基]-4'-氟丁酰苯

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C21H23ClFNO2
CAS号:
分子量:
375.86
EC號碼:
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

等級

certified reference material
pharmaceutical secondary standard

品質等級

agency

traceable to BP 407
traceable to Ph. Eur. H0100000
traceable to USP 1303002

API 家族

haloperidol

CofA

current certificate can be downloaded

包裝

pkg of 400 mg

技術

HPLC: suitable
gas chromatography (GC): suitable

應用

pharmaceutical (small molecule)

格式

neat

儲存溫度

2-30°C

SMILES 字串

OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3

InChI

1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2

InChI 密鑰

LNEPOXFFQSENCJ-UHFFFAOYSA-N

基因資訊

human ... HTR2A(3356)

正在寻找类似产品? 访问 产品对比指南

一般說明

Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Haloperidol is a major tranquilizer that is indicated for the treatment of schizophrenia, mania and neurological disorders including hyperkinesia.

應用

Haloperidol may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by high performance liquid chromatography (HPLC) and spectrophotometry techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

分析報告

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他說明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

腳註

To see an example of a Certificate of Analysis for this material enter LRAB7792 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

推薦產品

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

象形圖

Skull and crossbonesHealth hazard

訊號詞

Danger

危險分類

Acute Tox. 3 Oral - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Quantitative high performance liquid chromatographic determination of bamipine combined with tricyclic antidepressants and/or antipsychotics in pharmaceutical formulations.
Kountourellis JE, et al.
Analytical Letters, 26(10), 2171-2182 (1993)
Validation of derivative spectrophotometry method for determination of active ingredients from neuroleptics in pharmaceutical preparations.
Stolarczyk M, et al.
Acta Poloniae Pharmaceutica, 66(4), 351-356 (2009)
Determination and degradation study of haloperidol by high performance liquid chromatography.
Trabelsi H, et al.
Journal of Pharmaceutical and Biomedical Analysis, 29(4), 649-657 (2002)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门